骨性关节炎中lncRNA MEG3的表达及其与VEGF的相关性分析

摘要
图/表
参考文献(21)
相关文章 (15)

全文: PDF (648 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的检测长链非编码RNA母系表达基因3（lncRNA MEG3）和血管内皮生长因子（VEGF）在骨性关节炎（OA）软骨组织中的表达情况，并分析lncRNA MEG3表达与VEGF表达之间的相关性。方法 2014年1月~2015年12月，收集新疆维吾尔自治区中医医院40例原发性OA患者和20例志愿者的正常膝关节软骨组织；番红O对软骨组织进行染色后，改良Mankin评分标准对OA患者进行分组；实时定量荧光PCR试验检测各膝关节软骨组织中lncRNA MEG3和VEGF mRNA表达水平，酶联免疫吸附测定（ELISA）试验检测VEGF蛋白水平。Pearson相关系数法分析lncRNA MEG3表达与VEGF表达之间的相关性。结果 Real-time PCR结果显示，与正常软骨组织相比，lncRNA MEG3在OA患者软骨组织中相对表达量显著降低（P < 0.05），且软骨退化程度越高，lncRNA MEG3相对表达量越低（P < 0.05）。VEGF mRNA和VEGF蛋白相对表达量在OA患者软骨组织中均显著高于正常软骨组织（P < 0.05），且软骨退化程度越高，VEGF mRNA和VEGF蛋白相对表达量越高（P < 0.05）。Pearson相关分析结果显示，lncRNA MEG3表达与VEGF表达之间呈负相关（r = -0.466，P < 0.05）。结论 lncRNA MEG3在OA软骨组织中低表达，且与VEGF表达之间呈负相关，提示lncRNA MEG可能通过调节血管生成参与原发性OA的发生过程。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	刘振峰梁治权邓迎杰方锐孟庆才

关键词 ：骨性关节炎, 长链非编码RNA母系表达基因3, 血管内皮生长因子, 相关性

Abstract：Objective To determine the expressions of long non-coding RNA MEG3 (lncRNA MEG3) and vascular endothelial growth factor (VEGF) in the articular cartilage tissues of osteoarthritis (OA), and to analyze the correlation between the lncRNA MEG3 and VEGF. Methods The knee articular cartilage tissues from 40 cases of primary OA and 20 healthy volunteers were collected from January 2014 to December 2015 in Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region. After the safranin O staining, the OA patients were grouped according to the improved score criterion of Mankin. Real-time PCR assay was applied to detect the expressions of lncRNA MEG3 and VEGF mRNA in the knee articular cartilage tissues, and the ELISA assay was utilized to determine the protein level of VEGF. The correlation between the lncRNA MEG3 and VEGF was analyzed by the Pearson. Results The real-time PCR results showed that compared to the normal articular cartilage tissues, the lncRNA MEG3 was significantly downregulated in the OA articular cartilage tissues (P < 0.05), and the higher degree of degradation, the lower of lncRNA MEG3 (P < 0.05). Moreover, the mRNA and protein levels of VEGF were significantly upregulated in the OA articular cartilage tissues (P < 0.05), and the higher degree of degradation, the higher of VEGF (P < 0.05). The Pearson results showed that there was a negative relationship between the lncRNA MEG3 and VEGF (r = -0.466, P < 0.05). Conclusion lncRNA MEG3 was decreased in the articular cartilage tissues of OA, and lncRNA MEG3 was negatively correlated with the VEGF. lncRNA MEG3 may be involved in primary OA development through the regulation of angiogenesis.

Key words： Knee osteoarthritis Long non-coding RNA MEG3 Vascular endothelial grouth factor Correlation

基金资助:国家自然科学基金资助项目（81360549）。

通讯作者: 孟庆才（1964.12-），男，博士，主任医师；研究方向：骨与关节损伤的防治。

作者简介: 刘振峰（1982.7-），男，硕士；研究方向：骨与关节损伤的防治。

引用本文:

刘振峰梁治权邓迎杰方锐孟庆才. 骨性关节炎中lncRNA MEG3的表达及其与VEGF的相关性分析[J]. 中国医药导报, 2018, 15(16): 8-12.
LIU Zhenfeng LIANG Zhiquan DENG Yingjie FANG Rui MENG Qingcai. Expression of lncRNA MEG3 in the osteoarthritis and its correlation with VEGF. 中国医药导报, 2018, 15(16): 8-12.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2018/V15/I16/8

[1] Bijlsma JW，Berenbaum F，Lafeber FP. Osteoarthritis：an update with relevance for clinical practice [J]. Lancet，2011，377（9783）：2115-2126.
[2] Henrotin Y，Pesesse L，Lambert C. Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis [J]. Ther Adv Musculoskelet Dis，2014，6（1）：20-34.
[3] Lipovich L，Johnson R，Lin CY. MacroRNA underdogs in a microRNA world：evolutionary，regulatory，and biomedical significance of mammalian long non-protein-coding RNA [J]. Biochim Biophys Acta，2010，1799（9）：597-615.
[4] Brosnan CA，Voinnet O. The long and the short of noncoding RNAs [J]. Curr Opin Cell Biol，2009，21（3）：416-425.
[5] Bolton EM，Tuzova AV，Walsh AL，et al. Noncoding RNAs in prostate cancer：the long and the short of it [J]. Clin Cancer Res，2014，20（1）：35-43.
[6] Miyaki S，Asahara H. Macro view of microRNA function in osteoarthritis [J]. Nat Rev Rheumatol，2012，8（9）：543-552.
[7] Ponting CP，Oliver PL，Reik W. Evolution and functions of long noncoding RNAs [J]. Cell，2009，136（4）：629-641.
[8] Fu M，Huang G，Zhang Z，et al. Expression profile of long noncoding RNAs in cartilage from knee osteoarthritis patients [J]. Osteoarthritis Cartilage，2015，23（3）：423-432.
[9] Benetatos L，Vartholomatos G，Hatzimichael E. MEG3 imprinted gene contribution in tumorigenesis [J]. Int J Cancer，2011，129（4）：773-779.
[10] Gordon FE，Nutt CL，Cheunsuchon P，et al. Increased expression of angiogenic genes in the brains of mouse meg3-null embryos [J]. Endocrinology，2010，151（6）：2443-2452.
[11] 中华医学会骨科学分会.骨关节炎诊治指南（2007年版）[J].中华关节外科杂志：电子版，2007，27（4）：28-30.
[12] Fibel KH，Hillstrom HJ，Halpern BC. State-of-the-Art management of knee osteoarthritis [J]. World J Clin Cases，2015，3（2）：89-101.
[13] Zhang X，Rice K，Wang Y，et al. Maternally expressed gene 3（MEG3）noncoding ribonucleic acid：isoform structure，expression，and functions [J]. Endocrinology，2010， 151（3）：939-947.
[14] Wang P，Ren Z，Sun P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation [J]. J Cell Biochem，2012，113（6）：1868-1874.
[15] Mapp PI，Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis [J]. Nat Rev Rheumatol，2012，8（7）：390-398.
[16] Gerber HP，Vu TH，Ryan AM，et al. VEGF couples hypertrophic cartilage remodeling，ossification and angiogenesis during endochondral bone formation [J]. Nat Med，1999，5（6）：623-628.
[17] Harper J，Klagsbrun M. Cartilage to bone--angiogenesis leads the way [J]. Nat Med，1999，5（6）：617-618.
[18] Zhou Y，Zhong Y，Wang Y，et al. Activation of p53 by MEG3 non-coding RNA [J]. J Biol Chem，2007，282（34）：24 731-24 742.
[19] Zhou Y，Zhang X，Klibanski A. MEG3 noncoding RNA：a tumor suppressor [J]. J Mol Endocrinol，2012，48（3）：R45-R53.
[20] Pal S，Datta K，Mukhopadhyay D. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor（VPF/VEGF）expression in mammary carcinoma [J]. Cancer Res，2001，61（18）：6952-6957.
[21] Zhu J，Liu S，Ye F，et al. Long noncoding RNA MEG3 interacts with p53 protein and regulates partial p53 target genes in hepatoma cells [J]. PLoS One，2015，10（10）：e0139790.